Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1997-03-25
2000-11-21
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 4242341, 4242401, 4242411, 4242571, 4242611, 435 693, 4351723, A61K 3902, A61K 39108, A61K 39106, C12P 2106
Patent
active
061499196
ABSTRACT:
An immunogenic detoxified protein comprising the amino acid sequence of subunit A of cholera toxin (CT-A) or subunit A of an Escherichia coli heat labile toxin (LT-A) or a fragment thereof wherein one or more amino acids at, or in positions corresponding to Val-53, Ser-63, Val-97, Tyr-104 or Pro-106 are replaced with another amino acid or deleted. Examples of specific replacements include Val-53-Asp, Val-53-Glu, Val-53-Tyr, Ser-63-Lys, Val-97-Lys, Val-97-Tyr, Tyr-104-Lys, Tyr-104-Asp, Tyr-104-Ser, Pro-106-Ser. The immunogenic detoxified protein is useful as vaccine for Vibrio cholerae or an enterotoxigenic strain of Escherichia coli and is produced by recombinant DNA means by site-directed mutagenesis.
REFERENCES:
patent: 4666837 (1987-05-01), Harford et al.
patent: 4935364 (1990-06-01), Kaper et al.
Oseashon R. "Cholera", In Plotkin SA, Mortimer EA eds. Vaccines. Philadelphia, WB Saunders Co. 1988.
Pizza et al. Molecular Microbiology 14(1):51-60, 1994.
Lobet et al. Injection and Immunity 59(9):2870-2879, 1991.
Kaslow et al, Vaccine Research 1(1):47-54, 1992.
Burnette, W.N. et al., "Site-Specific Mutagenesis of the Catalytic Subunit of Cholera Toxin: Substituting Lysine for Arginine 7 Causes Loss of Activity", Inf. & Immun., 1991, 59, 4266-4270.
Dallas, W.S. et al., "Cistrons Encoding Escherichia coli Heat-Labile Toxin", J. Bacteriol., 1979, 139, 850-858.
Grant, C.C.R. et al., "Effect of Single Amino Acid Changes on the ADP-Ribosyltransferase Activity of Esherichia coli Heat-Labile Toxin Subunit A", 92nd Gen. Meet. Am. Soc. Microbiol., 1992, Abstract B289, 74.
Harford, S. et al., "Inactivation of the Escherichia coli heat-labile enterotoxin by in vitro mutagenesis of the A-subunit gene", Eur. J. Biochem., 1989, 183, 311-316.
Holmgren, J. et al., "Oral immunization against cholera", Curr. Top. Microbiol. Immunol., 1988, 146, 197-204.
Kaslow, H.R. et al., "Effects of Site-Directed Mutagenesis on Cholera Toxin A1 Subunit ADP-ribosytransferase Activity", 92nd Gen. Meet. Am. Soc. Mictrobiol., 1992, Abstract B291, 74.
Lai, C.Y. et al., "Location and Amino Acid Sequence Around the ADP-Ribosylation Site in the Cholera Toxin Active Subunit A.sub.1 ", Biochem. Biophys. Res. Comm., 1983, 116, 341-348.
Lebacq-Verheyden, A.M. et al., "Posttranslation Processing of Endogenous and of Baculovirus-Expressed Human Gastrin-Relaesing Peptide Precursor", Mol. Cell. Biol., 1988, 8, 3129-3135.
Lobet, Y. et al., "Effect of Site-Directed Mutagenic Alterations on ADP-Ribosyltransferase Activity of the A Subunit of Escherichia coli Heat-Labile Enterotoxin", Inf. & Immun., 1991, 59, 2870-2879.
Lycke, N. et al., "The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked t their ADP-ribosyltransferase activity", Eur. J. Immunol., 1992, 22, 2277-2281.
Mekalanos, J.J. et al., "Cholera toxin genes" nucleotide sequence, deletion analysis and vaccine development, Nature, 1983, 306, 551-557.
Pearson, G.D.N. et al., "Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12", Proc. Natl. Acad. Sci. USA, 1982, 79, 2976-2980.
Pickett, C.L. et al., "Genetics of Type Iia Heat-Labile Enterotoxin of Escherichia coli: Operon Fusions, Nucleotide Sequence, and Hybridization Studies", J. Bacteriol., 1987, 169, 5180-5187.
Sixma, T.K. et al., "Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli", Nature, 1991, 351, 371-377.
Spicer, E.K. et al., "Escherichia coli Heat-Labile Enterotoxin", Biol. Chem., 1982, 257, 5716-5721.
Tsuji, T. et al., "A Single Amino Acid Substitution in the A Subunit of Escherichia coli Enterotoxin Results in a Loss of Its Toxic Activity", J. Biol. Chem., 1990, 265, 22520-22525.
Yamamoto, T. et al., "Primary Structure of Heat-labile Enterotoxin Produced by Escherichia coli Pathogenic for Humans", J. Biol. Chem., 1984, 259, 5037-5044.
Domenighini Mario
Hol Wim
Pizza Mariagrazia
Rappuoli Rino
Biocine S.p.A.
Blackburn Robert P.
Harbin Alisa A.
Housel James C.
Portner Virginia
LandOfFree
Immunogenic detoxified mutants of cholera toxin and of the toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic detoxified mutants of cholera toxin and of the toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic detoxified mutants of cholera toxin and of the toxin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1254314